MariMed Inc.
MRMD
$0.104
$0.00151.46%
| Weiss Ratings | MRMD - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D- | |||
| Reward Grade | E | |||
| Rating Factors | MRMD - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Good | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | MRMD - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.84 | |||
| Price History | MRMD - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -5.45% | |||
| 30-Day Total Return | -9.64% | |||
| 60-Day Total Return | -22.96% | |||
| 90-Day Total Return | -36.00% | |||
| Year to Date Total Return | -15.38% | |||
| 1-Year Total Return | -49.04% | |||
| 2-Year Total Return | -75.81% | |||
| 3-Year Total Return | -85.56% | |||
| 5-Year Total Return | -29.49% | |||
| 52-Week High % Change | -69.85% | |||
| 52-Week Low % Change | 3.74% | |||
| Price | MRMD - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.34 | |||
| 52-Week Low Price | $0.10 | |||
| 52-Week Low Price (Date) | Mar 06, 2025 | |||
| 52-Week High Price (Date) | May 01, 2024 | |||
| Valuation | MRMD - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 39.08M | |||
| Enterprise Value | 137.52M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.04 | |||
| Earnings Per Share Growth | 1,780.00% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.25 | |||
| Price/Book (Q) | 0.56 | |||
| Enterprise Value/Revenue (TTM) | 0.87 | |||
| Price | $0.10 | |||
| Enterprise Value/EBITDA (TTM) | 7.66 | |||
| Enterprise Value/EBIT | 18.14 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | MRMD - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 380.60M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -0.85% | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | MRMD - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 781 277 0007 | |||
| Address | 10 Oceana Way Norwood, MA 02062 | |||
| Website | www.marimedinc.com | |||
| Country | United States | |||
| Year Founded | 2011 | |||
| Profitability | MRMD - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 4.80% | |||
| Profit Margin | -8.95% | |||
| Management Effectiveness | MRMD - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 2.35% | |||
| Return on Equity | -- | |||
| Income Statement | MRMD - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 157.86M | |||
| Total Revenue (TTM) | 157.86M | |||
| Revenue Per Share | $0.42 | |||
| Gross Profit (TTM) | 67.48M | |||
| EBITDA (TTM) | 17.95M | |||
| EBIT (TTM) | 7.58M | |||
| Net Income (TTM) | -14.13M | |||
| Net Income Avl. to Common (TTM) | -14.13M | |||
| Total Revenue Growth (Q YOY) | 4.62% | |||
| Earnings Growth (Q YOY) | 76.69% | |||
| EPS Diluted (TTM) | -0.04 | |||
| EPS Diluted Growth (Q YOY) | 76.32% | |||
| Balance Sheet | MRMD - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 9.79M | |||
| Cash Per Share (Q) | $0.03 | |||
| Total Current Assets (Q) | 56.68M | |||
| Total Preferred Equity (Q) | 19.00 | |||
| Total Equity (Q) | 86.84M | |||
| Current Ratio (Q) | 1.271 | |||
| Book Value Per Share (Q) | $0.18 | |||
| Total Assets (Q) | 212.68M | |||
| Total Current Liabilities (Q) | 44.60M | |||
| Total Debt (Q) | 89.44M | |||
| Total Liabilities (Q) | 125.84M | |||
| Total Common Equity (Q) | 69.58M | |||
| Cash Flow | MRMD - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -22.28M | |||
| Cash from Financing (TTM) | 8.38M | |||
| Net Change in Cash (TTM) | -3.47M | |||
| Levered Free Cash Flow (TTM) | -4.04M | |||
| Cash from Operations (TTM) | 10.43M | |||
